Biopsy indication—a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease
- 1 May 2004
- Vol. 63 (5) , 887-891
- https://doi.org/10.1016/j.urology.2003.11.032
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of Verification Bias on Screening for Prostate Cancer by Measurement of Prostate-Specific AntigenNew England Journal of Medicine, 2003
- Variation of Serum Prostate-Specific Antigen LevelsJAMA, 2003
- Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancerUrology, 2001
- Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomyUrology, 2001
- DIGITAL RECTAL EXAMINATION FOR DETECTING PROSTATE CANCER AT PROSTATE SPECIFIC ANTIGEN LEVELS OF 4 NG./ML. OR LESSJournal of Urology, 1999
- Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurementsJAMA, 1997
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993
- Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate CancerJournal of Urology, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991